Heike Knott

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Genetik

Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) Voskens C, Stoica D, Rosenberg M, Vitali F, Zundler S, Ganslmayer M, Knott H, et al. Journal article Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections (2021) Szumilas N, Corneth OB, Lehmann C, Schmitt H, Cunz S, Cullen JG, Chu T, et al. Journal article Role of the IL23/IL17 Pathway in Crohn’s Disease (2021) Schmitt H, Neurath M, Atreya R Journal article, Review article Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling (2021) Patankar JV, Lehmann M, Kühl AA, Atreya R, Becker C, Gonzalez-Acera M, Schmitt H, et al. Journal article Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab (2021) Fischer S, Cohnen S, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Journal article Siglec-15 on osteoclasts is crucial for bone erosion in serum-Transfer arthritis (2020) Korn M, Schmitt H, Angermüller S, Chambers D, Seeling M, Lux U, Brey S, et al. Journal article The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis (2020) Schmitt H, Ulmschneider J, Billmeier U, Scarozza P, Sonnewald S, Reid S, Atreya I, et al. Journal article, Original article Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab (2020) Scarozza P, Marafini I, Laudisi F, Troncone E, Schmitt H, Lenti MV, Costa S, et al. Journal article Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution Oligonucleotides-A Novel Promising Therapeutic Option for IBD (2019) Scarozza P, Schmitt H, Monteleone G, Neurath M, Atreya R Journal article, Review article